Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,185,988
in 8 filings, $4.8M under 10b5-1 plans

Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Option exercise 10b5-1 +5,000 $21.41 $107K 46,620
2025-03-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −2,621 $70.39 $184K 43,999
2025-03-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −2,267 $71.07 $161K 41,732
2025-03-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −112 $72.37 $8K 41,620
2025-03-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Option exercise · Stock Option (right to buy) 10b5-1 −5,000 144,497
2025-03-03 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Shares withheld for taxes −616 $72.10 $44K 41,620
2025-02-28 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Shares withheld for taxes −470 $73.02 $34K 42,236
2025-02-27 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Grant or award +14,484 42,706
2025-02-27 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Grant or award · Stock Option (right to buy) +48,357 48,357
2025-02-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Option exercise 10b5-1 +5,000 $21.41 $107K 33,222
2025-02-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −571 $87.77 $50K 32,651
2025-02-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −635 $89.09 $57K 32,016
2025-02-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −1,755 $89.95 $158K 30,261
2025-02-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −1,784 $91.05 $162K 28,477
2025-02-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −255 $91.71 $23K 28,222
2025-02-05 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Option exercise · Stock Option (right to buy) 10b5-1 −5,000 149,497
2025-01-06 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Option exercise 10b5-1 +5,000 $21.41 $107K 33,222
2025-01-06 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −954 $84.86 $81K 32,268
2025-01-06 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −3,921 $85.73 $336K 28,347
2025-01-06 Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC Sale 10b5-1 −125 $86.52 $11K 28,222

Page 1 of 6 · 115 trades